These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 28884730)
1. [Pharmacological effects and clinical application of pantogam and pantogam active]. Voronina TA; Litvinova SA Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(8):132-139. PubMed ID: 28884730 [TBL] [Abstract][Full Text] [Related]
2. [Pantogam activ (D-, L-hopantenic acid) in the treatment of cognitive and anxiety disorders in patients with arterial hypertension]. Smulevich AB; Volel BA; Ternovaya ES; Nikitina YM Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(12):40-49. PubMed ID: 26978493 [TBL] [Abstract][Full Text] [Related]
3. [Possible applications of rac-hopantenic acid in the treatment of cognitive, anxiety and depressive disorders in patients with essential arterial hypertension]. Ostroumova OD Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10):115-121. PubMed ID: 30499507 [TBL] [Abstract][Full Text] [Related]
4. [Possible applications of rac-hopantenic acid in the treatment of anxiety and depressive disorders in patients with chronic cerebral ischemia]. Gekht AB; Kanaeva LS; Avedisova AS; Marachev MP; Zakharova KV; Dashkina GK; Kulikova EV Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):45-57. PubMed ID: 28091501 [TBL] [Abstract][Full Text] [Related]
5. [Efficacy of pantogam in the treatment of hyperkinetic disorders in children]. Sukhotina NK; Konovalova VV; Kryzhanovskaia IL; Kupriianova TA Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):24-8. PubMed ID: 21311483 [TBL] [Abstract][Full Text] [Related]
6. [Efficacy and tolerability of pantogam activ in patients with partial epilepsy]. Poverennova IE; Iakunina AV; Kalinin VA; Savel'eva NN Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2):54-9. PubMed ID: 21350425 [TBL] [Abstract][Full Text] [Related]
7. [Pantogam in daily psychiatric practice]. Kontsevoĭ VA; Rotshteĭn VG; Bogdan MN; Riakhovskiĭ VV Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(12):34-9. PubMed ID: 18427457 [TBL] [Abstract][Full Text] [Related]
8. [Augmented antipsychotic therapy with pantogam active in patients with schizophrenia]. Medvedev VE; Frolova VI; Gushanskaya EV; Ter-Israelyan AU Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):28-34. PubMed ID: 26356612 [TBL] [Abstract][Full Text] [Related]
9. [Psychophysiological effects of combined administration of pantogam and potassium orotate in patients with neurotic disorders]. Ben'kovich BI; Gorshkova IA; Gershanovich II; Faĭzulloev AZ Eksp Klin Farmakol; 2001; 64(3):26-8. PubMed ID: 11558433 [TBL] [Abstract][Full Text] [Related]
10. [The role of combat stress in the development of chronic pain syndrom in veterans and its treatment by pantogam active]. Pal'tsev AI; Torgashov MN; Vorontsova IuS; Baiandina EV; Luniakina SB Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9):43-6. PubMed ID: 21246890 [No Abstract] [Full Text] [Related]
11. [Preventive and cessation therapy of mental disorders in patients with the acute coronary syndrome]. Medvedev VE; Epifanov AV; Zverev KV Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(4):42-8. PubMed ID: 22810740 [TBL] [Abstract][Full Text] [Related]
12. [Effects of nootropic agents on visual functions and lacrimal antioxidative activity in patients with primary open-angle glaucoma]. Davydova NG; Kuznetsova TP; Borisova SA; Abdulkadyrova MZh Vestn Oftalmol; 2006; 122(6):42-5. PubMed ID: 17217203 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacotherapy of psychomotor developmental delay in 6-12 months preterm infants with hypoxic-ischemic encephalopathy (the double-blind comparative multicenter placebo-controlled study)]. Zavadenko NN; Guzeva VI; Gaynetdinova DD; Davydova LA; Zavadenko AN; Romanova TA Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(10):30-39. PubMed ID: 31793540 [TBL] [Abstract][Full Text] [Related]
14. [Pantogam in the treatment of patients with organic brain lesions of different genesis]. Rogacheva TA; Mel'nikova TS; Krasnoslobodtseva LA; Nazmetdinova DM; Lapin IA Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(10):34-9. PubMed ID: 21183912 [TBL] [Abstract][Full Text] [Related]
15. [A differential approach to the improvement of prevention and correction of neuroleptic side extrapyramidal disorders with pantogam activ in patients with schizophrenia]. Tiganov AS; Panteleeva GP; Abramova LI; Bologov PV; Kananovich PS; Omel'chenko MA; Nikiforova IY Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2):72-80. PubMed ID: 28374697 [TBL] [Abstract][Full Text] [Related]
16. [The use of pantogam in patients with moderate cognitive disorders of vascular genesis]. Mikhaĭlova NA; Kamchatov PR Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(12 Suppl 2):47-50. PubMed ID: 20879105 [TBL] [Abstract][Full Text] [Related]
17. [Pantogam augmentation in hyperkinetic behavior disorder treatment]. Kupriyanova TA; Koren EV Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(6):66-69. PubMed ID: 27456906 [TBL] [Abstract][Full Text] [Related]
18. [New possibilities of pharmacotherapy in cardiovascular patients with mental disorders]. Medvedev VE; Frolova VI; Epifanov AV Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(9):30-7. PubMed ID: 25403298 [TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and correction of cognitive impairment in preschool age children with epilepsy]. Guzeva VI; Guzeva VV; Guzeva OV; Okhrim IV; Zgoda VN Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):51-55. PubMed ID: 26525622 [TBL] [Abstract][Full Text] [Related]
20. [Pantogam and pantogam active: qualitative and quantitative features of the interaction with neurotransmitter receptors in vitro]. Kovalev GI; Firstova IuIu; Abaimov DA; Starikova NA Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(3 Pt 1):39-43. PubMed ID: 22677754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]